✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Alembic Ltd.

ALEMBICLTD

Market Cap
₹2,728 Cr.
P/E
8.68

Alembic Ltd.

About
Alembic Limited is primarily engaged in two businesses i.e. (i) API Manufacturing which include, Estolate, Biphenyl Valine Oxalate and Venlafaxine; (ii) Real Estate which includes Residential Projects… Read more
Alembic Limited is primarily engaged in two businesses i.e. (i) API Manufacturing which includ… Read more
Low
85
52W Range
High
169
  • Alembic
  • Marathon NextgenReal
  • Hubtown
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    Suppliers
    • Balaji Amines Ltd.
    FAQs on Alembic Ltd. Business

    Alembic Limited is a company engaged in API Manufacturing, offering a range of products, and Real Estate, specializing in residential and commercial projects.

    Alembic major competitors are Marathon NextgenReal, Hubtown, Kolte-Patil Develop., Arvind Smartspaces, Ajmera Realty&Infra, AGI Infra, Unitech.
    Market Cap of Alembic is ₹2,752 Crs.
    While the median market cap of its peers are ₹2,791 Crs.

    Alembic seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Alembic Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Real Estate Sector
    Metrics for REIT investing - Motley Fool
    Fund Flow from Operations(FFO) - More Relevant than Net Income and EPS for REIT's - Motley Fool
    Real Estate : Why US Homebuilders went Asset Light - PPFAS
    What should you look for in an REIT? - Capital Mind
    What is a REIT - Kirtan A Shah
    Understand the Real Estate Sector - Scientific Investing
    THE BASICS: WOOD PANEL INDUSTRY - Omkara Capital
    Traverse the Indian Real Estate Universe with Anuj Puri - JioTalks
    How To Understand Accounting For Residential Real Estate - Scientific Investing
    Why Analyzing A Real Estate Company Through Financial Statements Is Misleading - Mihir Patki
    Revenue recognition in case of Real estate stocks - Ekansh Mittal
    Who Exactly Is Buying Expensive Mumbai Real Estate - Aman Goel
    Factors driving 'co-working' spaces - PPFAS
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material